Menas Abdelrhman Mohammed Abdalla | Molecular Pharmacology | Excellence in Research

Posted on by sciencefather

Ms. Menas Abdelrhman Mohammed Abdalla | Molecular Pharmacology | Excellence in Research 

Teaching Assistant of pharmacology, at ALNeelain University, Sudan.

A dedicated pharmacist and academic professional, Menas Abdelrhhman has over 8 years of experience as a Teaching Assistant in Pharmacology at Al-Neelain University, Sudan. With expertise in pharmacology, molecular biology, and genetics, she has contributed to both education and scientific research. Her technical skills include biochemical assays, molecular biology techniques, data analysis, and scientific writing. She has a strong passion for mentoring students, conducting research, and integrating innovative educational tools into pharmacology teaching. Additionally, she has clinical experience as a community and hospital pharmacist, contributing to patient care, inventory management, and pharmaceutical quality control. Currently, she serves as a Scientific Research Coordinator at the Deanship of Scientific Research, actively participating in research ethics and proposal evaluation. With a commitment to continuous learning and professional development, Menas has attended multiple international workshops and conferences to stay at the forefront of pharmaceutical sciences and molecular medicine.

Professional Profile

Scopus

🎓 Education

Menas Abdelrhhman pursued a Master’s degree in Molecular Medicine from Al-Neelain University, Khartoum, Sudan, which she is set to complete by December 2024. This program has provided her with advanced knowledge in molecular biology, genetics, and research methodologies related to pharmacology and disease mechanisms.

She obtained her Bachelor’s degree in Pharmacy from Al-Neelain University in 2013, graduating with a CGPA of 81.04%. During her undergraduate studies, she developed a strong foundation in pharmacology, medicinal chemistry, clinical pharmacy, and patient care.

Beyond formal education, she has attended various international training programs on topics such as bioinformatics, research bioethics, diabetes management, and clinical trials, demonstrating her commitment to professional growth. Her educational background equips her with a comprehensive understanding of molecular medicine and its applications in pharmacology, genetics, and patient-centered healthcare.

👩‍🏫 Professional Experience

Menas has been serving as a Teaching Assistant of Pharmacology at Al-Neelain University since January 2016. She has conducted practical sessions, developed course materials, assessed students’ assignments, and provided academic support to more than 500 students. She also integrates educational technologies, such as multimedia presentations and online simulations, to enhance the learning experience.

In 2023, she took on the role of Scientific Research Coordinator at the Deanship of Scientific Research, participating in ethics committee meetings, proposal evaluations, and research day organization.

Her clinical experience includes working as a Community Pharmacist and Technical Manager at Jood Modern Pharmacy (2018–2023), where she managed inventory, resolved insurance claims, and supervised junior pharmacists. She also gained hospital pharmacy experience at Aljabal Military Hospital (2014–2015) and worked as a House-Officer Pharmacist at the Federal Ministry of Health (2013–2014).

Currently, she is also a trainee at Alwakrah Health Center in Qatar, expanding her expertise in primary healthcare and clinical pharmacy.

🔎 Research Interests

Menas Abdelrhhman’s research interests revolve around pharmacogenetics, molecular pharmacology, and personalized medicine. She is particularly focused on:

  • Genetic polymorphisms and drug response: Investigating the role of gene variations in drug metabolism, particularly in conditions like bronchial asthma and metabolic disorders.
  • Molecular mechanisms of disease: Studying how molecular pathways contribute to disease progression and how they can be targeted for drug development.
  • Bioinformatics and genomics: Using computational tools to analyze genetic variations and their impact on drug efficacy and adverse reactions.
  • Clinical pharmacology and drug safety: Assessing drug interactions, side effects, and optimizing treatment regimens for better patient outcomes.

Through her role in research ethics committees and proposal evaluations, she ensures that scientific studies adhere to ethical standards and contribute meaningfully to pharmaceutical science.

🏆 Awards & Recognitions

Menas Abdelrhhman has been recognized for her academic excellence, research contributions, and professional dedication. Some notable achievements include:

  • Best Ph.D. Research Proposal Award (2024) – Recognized for her outstanding research proposal in molecular medicine at Al-Neelain University.
  • Young Researcher Award (2023) – Awarded for significant contributions to pharmacology and genetics research.
  • Outstanding Teaching Assistant Award (2022) – Acknowledged for exceptional mentorship and dedication to student education.
  • Excellence in Pharmaceutical Practice (2021) – Recognized for reducing expired drug inventory by 60% through proactive inventory management at Jood Modern Pharmacy.
  • Best Pharmacology Research Presentation (2018) – Honored for presenting groundbreaking research on β2-Adrenergic Receptor Gene Polymorphisms in asthma patients.

Her commitment to research, teaching, and clinical pharmacy has made her a valuable contributor to the field of pharmaceutical sciences.

📚 Top Noted Publications

Menas Abdelrhhman has contributed to peer-reviewed journals, focusing on genetic polymorphisms and respiratory diseases. Below are her latest publications:

1. IL13 Gene Polymorphisms Among Sudanese Patients with Bronchial Asthma: A Case-Control Study

  • Authors: Menas A. Abdalla and Hamdan Z. Hamdan
  • Journal: Molecular Biology Research Communications
  • Volume: 14
  • Issue: 1
  • Year: 2025
  • Pages: 27–30
  • DOI: 10.22099/mbrc.2024.50865.2017
  • URL: https://mbrc.shirazu.ac.ir/article_7725.html

2. β2-Adrenergic Receptor Gene Polymorphisms p.Gly16Arg and p.Glu27Gln in Sudanese Patients with Bronchial Asthma: A Case-Control Study

Conclusion

The candidate has a strong foundation in pharmacology, molecular biology, and genetics, along with solid teaching and research coordination experience. Their recent publications, technical expertise, and leadership in research ethics make them a competitive candidate for Excellence in Research Awards.
However, to further strengthen their profile, they should publish in high-impact journals, lead funded research projects, and expand international collaborations. Overall, highly suitable for research recognition with further potential for academic growth.

Yong-Xiao Wang | Drug Discovery Research | Best Researcher Award

Posted on by sciencefather

Dr. Yong-Xiao Wang | Drug Discovery Research | Best Researcher Award 

Principal Investigator, at Albany Medical College, United States.

Dr. Yong-Xiao Wang is a distinguished professor in Molecular & Cellular Physiology at Albany Medical College. With a profound dedication to cardiovascular and respiratory research, he has become a key figure in exploring molecular mechanisms within these fields. His research examines cell calcium signaling, ion channels, and reactive oxygen species in cardiovascular and respiratory systems. Dr. Wang has garnered substantial funding through NIH and AHA grants, contributing to groundbreaking discoveries in cellular signaling pathways. A prolific author, he has published extensively in high-impact journals, such as Nature and Proceedings of the National Academy of Sciences. Dr. Wang also actively participates in scientific editorial boards and professional societies, embodying a deep commitment to advancing translational medicine and mentoring future leaders in physiology and pharmacology.

Profile

Scopus

Education 🎓

Dr. Wang completed his M.D. equivalent in 1983 from Wannan Medical College, China, setting the foundation for his medical and scientific journey. He pursued advanced studies at the Fourth Military Medical University in Xian, earning his M.S. in 1986 and later a Ph.D. in 1990. This robust academic background enabled him to acquire deep insights into pharmacology and physiology, essential for his focus on cardiovascular and respiratory biology. His education honed his expertise in molecular biology, with an emphasis on cell signaling mechanisms and regulatory pathways, forming the basis for his impactful research career in molecular and cellular physiology.

Experience 📚

Dr. Wang’s professional trajectory spans several decades and prestigious institutions. He has served as a tenured professor at Albany Medical College since 2006. Previously, he held roles as an associate professor and senior research associate at Cornell University and the University of Pennsylvania, where he gained extensive research experience. Early in his career, Dr. Wang held positions at the Fourth Military Medical University in China. His multifaceted experience encompasses research, teaching, and mentorship, reinforcing his expertise in translational medicine and his commitment to innovation in cardiovascular and respiratory sciences.

Research Interests 🔬

Dr. Wang’s research focuses on cardiovascular and respiratory biology, particularly investigating cellular signaling mechanisms. His studies delve into calcium signaling, ion channels, reactive oxygen species, and neurotransmitter receptors in cardiovascular and respiratory systems. Dr. Wang employs molecular, biochemical, and pharmacological approaches to understand these processes, aiming to uncover therapeutic pathways for heart and lung diseases. His translational research bridges cellular mechanisms and clinical applications, aiming to develop novel therapies for conditions such as pulmonary hypertension and cardiac hypertrophy, underscoring his commitment to advancing human health.

Awards 🏆

Dr. Wang has been recognized widely for his contributions to medical research. His accolades include the American Heart Association’s Established Investigator Award in 2003 and the Scientist Development Award in 1998. In 2020, he was elected a Fellow of the American Physiology Society, reflecting his influence in the field. Additionally, he has received Outstanding Research Awards from the Chinese Heart Association and Chinese Pharmacology Society, acknowledging his research impact across both national and international platforms. Dr. Wang’s awards highlight his consistent excellence in cardiovascular and respiratory research.

Top Noted Publications 📑

Dr. Wang has authored numerous influential publications in high-impact journals, reflecting his extensive contributions to cardiovascular and respiratory research. Key publications include:

  • “Effects of doxorubicin on excitation-contraction coupling in guinea-pig ventricular myocardium”
    Published in Circulation Research, 1995

    • This study explores the cellular mechanisms by which doxorubicin, a chemotherapeutic agent, affects heart muscle contraction. It investigates the impact on excitation-contraction coupling in guinea pig ventricular myocardium, shedding light on the cardiovascular side effects of doxorubicin treatment.
    • Cited by: 500+ articles
  • “Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy”
    Published in Nature, 2002

    • This research delves into the protective role of oestrogen in preventing cardiac hypertrophy in FKBP12.6 null mice. The study highlights the significance of estrogen in modulating cardiac function and its potential therapeutic implications in preventing heart enlargement and dysfunction.
    • Cited by: 1000+ articles
  • “Rieske iron-sulfur protein induces remodeling of FKBP12.6/RyR2 complex”
    Published in Nature Communications, 2020

    • This paper examines the role of the Rieske iron-sulfur protein in the remodeling of the FKBP12.6/RyR2 complex, a critical component of the calcium release channel in cardiac muscle cells. This work helps to understand the molecular basis of arrhythmias and cardiac dysfunction.
    • Cited by: 200+ articles

Conclusion

Dr. Yong-Xiao Wang is a highly qualified candidate for the Research for Best Researcher Award. His significant contributions to the understanding of molecular mechanisms in respiratory and cardiovascular diseases, along with his extensive publication record, grant achievements, and leadership in academia, underscore his suitability for this recognition. With continued focus on interdisciplinary research and public health applications, Dr. Wang’s influence in the biomedical sciences could become even more impactful, making him a compelling choice for this award.